---
title: "Six-month outcomes from phase-one trial of anti-inflammatory drug to assess benefit in acute DVT patients demonstrate ‘promise’"
date: "2023-10-31T16:30:39.000Z"
publishedDate: "31 octobre 2023"
summary: "The open-label phase of the DEXTERITY-AFP trial investigating the Bullfrog microinfusion device—which involves the perivenous injection of the anti-inflammatory drug dexamethasone to improve patency and post-thrombotic syndrome (PTS) six months after thrombus removal in symptomatic deep vein thrombosis (DVT) patients—has shown positive results. That&#8217;s according to late-breaking data revealed during The VEINS 2023 meeting (Oct."
importance: ""
sourceUrl: "https://vascularnews.com/six-month-outcomes-from-phase-one-trial-of-anti-inflammatory-drug-to-treat-pts-in-dvt-patients-demonstrate-promise/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2023-10-31-six-month-outcomes-from-phase-one-trial-of-anti-inflammatory-drug-to-assess-benefit-in-acute-dvt-patients-demonstrate-promise"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2023/10/Dexter-VIVA-2023.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/six-month-outcomes-from-phase-one-trial-of-anti-inflammatory-drug-to-treat-pts-in-dvt-patients-demonstrate-promise/"
---

![Six-month outcomes from phase-one trial of anti-inflammatory drug to assess benefit in acute DVT patients demonstrate ‘promise’](https://vascularnews.com/wp-content/uploads/sites/7/2023/10/Dexter-VIVA-2023.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/six-month-outcomes-from-phase-one-trial-of-anti-inflammatory-drug-to-treat-pts-in-dvt-patients-demonstrate-promise/*

## L’essentiel

The open-label phase of the DEXTERITY-AFP trial investigating the Bullfrog microinfusion device—which involves the perivenous injection of the anti-inflammatory drug dexamethasone to improve patency and post-thrombotic syndrome (PTS) six months after thrombus removal in symptomatic deep vein thrombosis (DVT) patients—has shown positive results. That&#8217;s according to late-breaking data revealed during The VEINS 2023 meeting (Oct.

## Lien source

https://vascularnews.com/six-month-outcomes-from-phase-one-trial-of-anti-inflammatory-drug-to-treat-pts-in-dvt-patients-demonstrate-promise/
